Visura Announces Closing of Series B Financing

Summation

  • , a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophageal echocardiogram (TEE) probe intubations, announced today the completion of the company’s $4 million Series B financing.
  • , Visura also launched a new product update in 2022, expanding the usage of the TEECAD System to include the Philips X8-2t Transducer.
  • In addition to securing Series B funding, Visura recently received a Launch Minnesota Innovation Grant issued by the Minnesota Department of Employment and Economic Development.

Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophageal echocardiogram (TEE) probe intubations, announced today the completion of the company’s $4 million Series B financing. The funding is led by a strategic investor with participation from both new and existing investors.

“These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System,” says Christine Horton, president and CEO of Visura. “With this financing, our TEECAD System will make a positive impact for more patients, cardiologists and the healthcare system. We are incredibly grateful for our investors and partners, and we look forward to what’s next for Visura.”

Visura’s TEECAD System is the world’s first FDA-cleared disposable camera that seamlessly connects to TEE probes. TEECAD provides physicians with real-time visualization during esophageal intubation for more efficient and effective probe placement. There are an estimated 650,000 TEE procedures performed annually in the U.S. with TEE procedures growing at an annual rate of 7%. Use of the TEECAD System for efficient and accurate probe placement with fewer complications supports the healthcare system’s goal of zero hospital-acquired complications.

In addition to securing Series B funding, Visura recently received a Launch Minnesota Innovation Grant issued by the Minnesota Department of Employment and Economic Development. The grant targets the most promising, innovative and scalable technology businesses in Minnesota. To bring the technology to heart centers across the U.S., Visura also launched a new product update in 2022, expanding the usage of the TEECAD System to include the Philips X8-2t Transducer. Visura continues to work to expand the TEECAD System’s compatibility with other echocardiography transducer probes.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine

Funding will accelerate the commercialization and adoption of the MyPhenome™ test in the obesity specialist market and the wider industry. The MyPhenome test equips physicians with essential tools to develop effective treatment plans including lifestyle and diet intervention as well as medication and/or procedure recommendations reports Phenomix Sciences.

R3 Vascular Announces $87 Million in Series B Financing

R3 Vascular will use the proceeds to support the ELITE FDA IDE pivotal trial of its best-in-class bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD. 

Nami Surgical Secures Investment to Transform Robotic-Assisted Surgery Market

Nami Surgical develops miniaturised ultrasonic medical devices for surgical applications, and supports medical device companies to deliver innovation in ultrasonic surgery. In a groundbreaking development, Nami has introduced a high-performance, miniaturised ultrasonic scalpel, overcoming significant barriers in robotic-assisted surgery. Traditionally favoured in laparoscopic procedures, ultrasonic scalpels have been too large for effective use in robotic surgery until now.

By using this website you agree to accept Medical Device News Magazine Privacy Policy